Abstract
Although the pathophysiology of microvascular angina is unclear, intracellular metabolic changes are believed to be the main factors. Trimetazidine has an intracellular metabolic effect in coronary insufficiency. The effect of trimetazidine in microvascular angina is unknown. Thirty-five patients (8 men, 27 women, age 36–57 years, mean 43.9±6.4 years) with microvascular angina were included in this study. The effects of trimetazidine (60 mg daily) were investigated in a placebo-controlled, doubleblind study consisting of two 4-week treatment periods. Patients were assessed by symptom-limited exercise testing (Bruce protocol). Heart rate and systolic blood pressure at rest, peak exercise, and the time of 1 mm ST segment depression were not significantly different between placebo and trimetazidine treatment. Trimetazidine prolonged total exercise time and time to 1 mm ST depression compared with placebo. Maximum ST depression was less in patients with trimetazidine therapy than those with placebo. It is concluded that trimetazidine has a beneficial effect in cases with microvascular angina.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kemp HG, Elliott WC, Gorlin R (1967) The anginal syndrome with normal coronary arteriography. Trans Assoc Am Physicians 80:59–70.
Conti CR (1993) What is syndrome X? Clin Cardiol 16:1–3.
Tweddel AC, Martin W, Hutton I Thallium scans in syndrome X. Br Heart J 68:48–50.
Sarrel PM, Lindsay D, Rosano GM, Poole-Wilson PA (1992) Angina and normal coronary arteries in women. Gynecologic findings. Am J Obstet Gynecol 167:467–471.
Rosano GMC, Collins P, Kaski JC, Lindsay DR, Sarrel PM, Poole-Wilson PA (1995) Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 16:610–614.
Kaski JC, Rosano GMC, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson (1995) Cardiac syndrome X: Clinical characteristics and left ventricular function. J Am Coll Cardiol 25:807–814.
Eriksson B, Suedenhag J, Martinsson A, Sylven C (1995) Effect of epineprine infusion on chest pain in syndrome X in the absence of signs of myocardial ischemia. Am C Cardiol 75:241–245.
Frobert O, Molgaard H, Botker HE, Bagger JP (1995) Autonomic balance in patients with angina and normal coronary angiogram. Eur Heart J 16:1356–1360.
Rosano MMC, Ponikowski P, Adamopoulos S, Collins P, Poole-Wilson PA, Coats AJS, Kaski JC (1994) Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 73:1174–1179.
Chauhan A, Mullins PA, Petch MC, Schofield PM (1994) is coronary flow reserve in response to papaverine really normal in syndrome X. Circulation 89:1998–2004.
Montorsi P, Fabbiocchi F, Loaldi A, Amoni L, Polese A, DeCesare N, Guazzi MD (1991) Coronary adrenergic hyperactivity in patients with syndrome X and abnormal electrocardiogram at rest. Am J Cardiol 68:1698–1703.
Crea F, Maseri A (1991) Epicardial coronary artery tone and reactivity in patients with normal coronary arteriograms and reduced coronary flow reserve (syndrome X). J Am Coll Cardiol 18:50–54.
Camici PG, Marraccini P, Gistri R, Salvadori PA, Sorace O, L'Abbate A (1994) Adrenergically mediated coronary vasoconstriction in patients with syndrome X. Cardiovasc Drugs Ther 8:221–226.
Dean JD, Jones CJ, Hutchinson SJ, Peters JR, Henderson AH (1991) Hyperinsulinaemia and microvascular angina (syndrome X). Lancet 337:456–457.
Chauhan A, Foote J, Petch MC, Schofield PM (1994) Hyperinsulinemia, coronary artery disease and syndrome X. J Am Coll Cardiol 23:364–368.
Godsland IF, Crook D, Stevenson JC, Collins P, Rosano GMC, Lees B, Sidhu M, Poole-Wilson PA (1995) Insulin resistance syndrome in postmenopausal women with cardiological syndrome X. 74:47–52. postmenopausal women with cardiological syndrome X. 74:47–52.
Lange K, Nienaber CA, Volk C, Schneider MRE, Koschyk DH. Rinninger F, Meinertz T (1995) Insulin resistance and hyperlipoproteinemia in microvascular angina: Risk factor or pathogenetic link? Coronary Artery Dis 6:797–804.
Swan JW, Walton C, Godsland IF, Crook D, Oliver MF, Stevenson JC (1994) Insulin resistance syndrome as a feature of cardiological syndrome X is non-obese men. Br Heart J 71:41–44.
Vestergaard H, Skett P, Stefensen R, Wroblewbki H, Pedersen O, Kastrup J (1995) Insulin-resistant glucose metabolism in patients with microvascular angina-syndrome X. Metabolism 44:876–882.
Emdin M, Picano E, Lattanzi F, L'Abbate A (1989) Improved exercise capacity with acute aminophylline administration in patients with syndrome X. J Am Coll Cardiol 14:1450–1453.
Vrints CJM, Bult H, Hitter E, Herman AG, Snoeck JP (1992) Impaired endothelium-dependent cholinergic coronary vasodilatation in patients with angina and normal coronary arteriograms. J Am Coll Cardiol 19:21–31.
Poole-Wilson PA, Crake T (1989) The enigma of syndrome X. Int J Microcirc Clin Exp 8L423–8L432.
Chauhan A (1995) Syndrome X—angina and normal coronary angiography. Postgrad Med J 71:341–345.
Kaski JC, Elliott PM (1995) Angina pectoris and normal coronary arteriograms. Clinical presentation and hemodynamic characteristics. Am J Cardiol 76:35D-42D.
Montorsi P, Cozzi S, Loaldi A, Fabbiocchi F, DeCesare N, Guazzi MD (1990) Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X. Am J Cardiol 66:302–307.
Kaski JC, Rosano G (1994) Effect of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol 23:652–657.
Yoshio H, Shimizu M, Kita Y, Ino H, Kaku B, Taki J, Takeda R (1995) Effects of short-term aminophylline administration on cardiac functional reserve in patients with syndrome X. J Am Coll Cardiol 25:1547–1551.
Radice M, Giudici V, Albertini A, Mannarini A (1994) Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X. Am Heart J 127:531–535.
Lonza GA, Manzoli A, Bio E, Crea F, Maseri A (1994) Acute effects of nitrates on exercise testing in patients with syndrome X. Circulation 90:2695–2700.
Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P (1994) Trimetazidine: A new concept in the treatment of angina—comparison with propranolol in patients with stable angina. Br J Clin Pharmacol 37:279–288.
Seller P, Audoin B, Payen B, Corona P, Duogn TC, Ourback P (1987) Acute effects of trimetazidine evaluated by exercise testing. Eur J Pharmacol 33:205–207.
Dalla-Volta S, Maraglino G, Della-Valentina B, Viena P, Desideri A (1990) Comparison of trimetazidine with nifedipine in effort angina: A double-blind study. Cardiovasc Drug Ther 4:853–860.
Broitter L, Barat JL, Combe C, Broussens B, Bonnet J, Bricaud H (1990) Therapeutic value of a cardioprotective agent in patients with severe ischemic cardiomyopathy. Eur Heart J 11:207–212.
Fabiani JN, Ponzio O, Emerit I, Massonet-Castel S, Paris M, Chevalier P, Jabara V, Carpentier A (1992) Cardio-protective effect of trimetazidine during coronary artery graft surgery. Cardiovasc Surg 33:486–491.
Kober G, Bück T, Sievert H, Vallbracht C (1992) Myocardial protection during percutaneous transluminal coronary angioplasty: Effect of trimetazidine. Eur Heart J 13:1109–1115.
Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T (1994) Small vessel pathology and coronary hemodynamics in patients with micro-vascular angina. Int J Cardiol 43:139–150.
Wiedermann JG, Schwartz A, Apfelbaum M (1995) Anatomic and physiologic heterogeneity in patients with syndrome X. J Am Coll Cardiol 25:1310–1317.
Harpey C, Clauser P, Labrid C, Freyria JL, Poirier JP (1989) Trimetazidine, a cellular anti-ischemic agent. Cardiovasc Drug Rev 6:292–312.
Renaud JF (1988) Internal pH, Na+ and Ca++ regulation by trimetazidine during cardiac cell acidosis. Cardiovasc Drug Ther 1:677–686.
D'Alche P (1990) Electrocardiographical assessment of trimetazidine anti-ischemic properties. Cardiovasc Drug Ther 4:810–811.
Author information
Authors and Affiliations
About this article
Cite this article
Nalbantgil, S., Altintig, A., Yilmaz, H. et al. The effect of trimetazidine in the treatment of microvascular angina. International Journal of Angiology 8, 40–43 (1999). https://doi.org/10.1007/BF01616842
Issue Date:
DOI: https://doi.org/10.1007/BF01616842